$DXCM
DEXCOM INC Stock $dxcm

$dxcm Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000109355717000221 Filed on November 01, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$221.0M	$184.6M	$148.6M
YoY Change	29.09%	24.23%	41.25%
Cost Of Revenue	$67.50M	$57.60M	$47.50M
YoY Change	23.85%	21.26%	55.74%
Gross Profit	$153.5M	$127.0M	$101.1M
YoY Change	31.53%	25.62%	35.34%
Gross Profit Margin	69.46%	68.8%	68.03%
Selling, General & Admin	$92.80M	$84.20M	$75.70M
YoY Change	17.32%	11.23%	44.74%
% of Gross Profit	60.46%	66.3%	74.88%
Research & Development	$48.70M	$43.30M	$43.90M
YoY Change	11.44%	-1.37%	-32.25%
% of Gross Profit	31.73%	34.09%	43.42%
Depreciation & Amortization	$16.10M	$4.300M	$4.100M
YoY Change	347.22%	4.88%	51.85%
% of Gross Profit	10.49%	3.39%	4.06%
Operating Expenses	$141.5M	$127.5M	$119.6M
YoY Change	15.23%	6.61%	2.13%
Operating Profit	$12.00M	-$500.0K	-$18.50M
YoY Change	-296.72%	-97.3%	-56.37%
Interest Expense	-$3.300M	$4.500M	$200.0K
YoY Change	1550.0%	2150.0%	100.0%
% of Operating Profit	-27.5%
Other Income/Expense, Net	-$100.0K	$1.300M	$0.00
YoY Change	-85.71%
Pretax Income	$12.40M	-$2.500M	-$18.60M
YoY Change	-277.14%	-86.56%	-56.24%
Income Tax	$1.600M	-$500.0K	$200.0K
% Of Pretax Income	12.9%
Net Earnings	-$9.400M	-$2.000M	-$18.80M
YoY Change	27.03%	-89.36%	-55.76%
Net Earnings / Revenue	-4.25%	-1.08%	-12.65%
Basic Earnings Per Share	-$0.11	-$0.02
Diluted Earnings Per Share	-$0.11	-$0.02	-$223.5K
COMMON SHARES
Basic Shares Outstanding	86.90M shares	86.70M shares	83.88M shares
Diluted Shares Outstanding		86.70M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$548.6M	$525.8M	$127.3M
YoY Change	343.49%	313.04%	12.36%
Cash & Equivalents	$441.5M	$402.1M	$97.70M
Short-Term Investments	$107.1M	$123.7M	$29.60M
Other Short-Term Assets	$16.60M	$13.30M	$9.800M
YoY Change	80.43%	35.71%	145.0%
Inventory	$45.20M	$43.30M	$44.70M
Prepaid Expenses
Receivables	$134.3M	$110.5M	$76.80M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$744.7M	$692.9M	$258.6M
YoY Change	165.96%	167.94%	26.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$145.6M	$136.1M	$88.40M
YoY Change	33.09%	53.96%	89.7%
Goodwill	$12.10M	$12.00M	$11.80M
YoY Change	7.08%	1.69%	218.92%
Intangibles			$1.600M
YoY Change			-33.33%
Long-Term Investments
YoY Change
Other Assets	$1.700M	$1.900M	$1.500M
YoY Change	-19.05%	26.67%	400.0%
Total Long-Term Assets	$159.4M	$150.0M	$103.3M
YoY Change	29.8%	45.21%	94.91%
TOTAL ASSETS
Total Short-Term Assets	$744.7M	$692.9M	$258.6M
Total Long-Term Assets	$159.4M	$150.0M	$103.3M
Total Assets	$904.1M	$842.9M	$361.9M
YoY Change	124.45%	132.91%	40.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.70M	$23.30M	$26.30M
YoY Change	90.61%	-11.41%	57.49%
Accrued Expenses	$89.00M	$92.60M	$59.30M
YoY Change	15.58%	56.16%	56.05%
Deferred Revenue	$3.200M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$138.9M	$118.2M	$86.10M
YoY Change	35.64%	37.28%	46.43%
LONG-TERM LIABILITIES
Long-Term Debt	$334.3M	$330.7M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$18.20M	$16.70M	$14.00M
YoY Change	9.64%	19.29%	233.33%
Total Long-Term Liabilities	$18.20M	$16.70M	$14.00M
YoY Change	9.64%	19.29%	233.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$138.9M	$118.2M	$86.10M
Total Long-Term Liabilities	$18.20M	$16.70M	$14.00M
Total Liabilities	$484.7M	$458.9M	$100.1M
YoY Change	307.31%	358.44%	57.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$671.8M	-$662.4M	-$613.6M
YoY Change	8.18%	7.95%	10.18%
Common Stock	$1.094B	$1.049B	$876.0M
YoY Change	20.76%	19.69%	16.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change
Treasury Stock Shares	0.000 shares
Shareholders Equity	$419.4M	$384.0M	$261.8M
YoY Change
Total Liabilities & Shareholders Equity	$904.1M	$842.9M	$361.9M
YoY Change	124.45%	132.91%	40.98%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$9.400M	-$2.000M	-$18.80M
YoY Change	27.03%	-89.36%	-55.76%
Depreciation, Depletion And Amortization	$16.10M	$4.300M	$4.100M
YoY Change	347.22%	4.88%	51.85%
Cash From Operating Activities	$41.20M	$36.20M	$23.00M
YoY Change	209.77%	57.39%	28.49%
INVESTING ACTIVITIES
Capital Expenditures	-$17.60M	-$13.50M	-$16.10M
YoY Change	0.0%	-16.15%	117.57%
Acquisitions
YoY Change
Other Investing Activities	$16.50M	-$23.10M	-$1.700M
YoY Change	5400.0%	1258.82%	-200.0%
Cash From Investing Activities	-$1.100M	-$36.60M	-$17.80M
YoY Change	-93.64%	105.62%	212.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	4.300M	5.100M
YoY Change	-80.0%	-15.69%	-5.56%
NET CHANGE
Cash From Operating Activities	41.20M	36.20M	23.00M
Cash From Investing Activities	-1.100M	-36.60M	-17.80M
Cash From Financing Activities	100.0K	4.300M	5.100M
Net Change In Cash	40.20M	3.900M	10.30M
YoY Change	-1248.57%	-62.14%	-41.48%
FREE CASH FLOW
Cash From Operating Activities	$41.20M	$36.20M	$23.00M
Capital Expenditures	-$17.60M	-$13.50M	-$16.10M
Free Cash Flow	$58.80M	$49.70M	$39.10M
YoY Change	90.29%	27.11%	54.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2300000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001093557
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	86903145	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	DEXCOM INC
	dei	Trading Symbol TradingSymbol	DXCM
CY2016Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	4500000	USD
CY2017Q3	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	10600000	USD
	dxcm	Acquisitionrelatedholdbackliability Acquisitionrelatedholdbackliability	1800000	USD
	dxcm	Acquisitionrelatedholdbackliability Acquisitionrelatedholdbackliability	0	USD
	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	6000000	USD
	dxcm	Capitalized Costs And Financing Liability CapitalizedCostsAndFinancingLiability	0	USD
CY2016Q4	dxcm	Clinical Trials ClinicalTrials	1100000	USD
CY2017Q3	dxcm	Clinical Trials ClinicalTrials	400000	USD
CY2017Q3	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2016Q4	dxcm	Financing Lease Obligation FinancingLeaseObligation	6700000	USD
CY2017Q3	dxcm	Financing Lease Obligation FinancingLeaseObligation	6700000	USD
CY2016Q4	dxcm	Pharmacy Rebates PharmacyRebates	8200000	USD
CY2017Q3	dxcm	Pharmacy Rebates PharmacyRebates	15200000	USD
	dxcm	Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm	P1Y
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	101700000	USD
	dxcm	Revenue Recognition Sales Returns Coverage Period RevenueRecognitionSalesReturnsCoveragePeriod	P30D
CY2016Q3	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	5200000	USD
	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	18700000	USD
CY2017Q3	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	5400000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	110500000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47200000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	52300000	USD
	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	13900000	USD
CY2017Q3	dxcm	Working Capital WorkingCapital	574700000	USD
CY2016Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	68100000	USD
CY2017Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	80600000	USD
CY2016Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	24500000	USD
CY2017Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	23300000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2200000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	905700000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1048500000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	100000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5700000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7200000	shares
CY2016Q4	us-gaap	Assets Assets	402800000	USD
CY2017Q3	us-gaap	Assets Assets	842900000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	280000000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	692900000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	29200000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	123700000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	29200000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	123700000	USD
CY2017Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	103900000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29200000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	123700000	USD
CY2017Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	19800000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86100000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97700000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94500000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	402100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11600000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	307600000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	525800000	USD
CY2016Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	32300000	USD
CY2017Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	327000000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84900000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87200000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84600000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86900000	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2017Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58600000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42000000	USD
CY2017Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	357200000	USD
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2017Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	324000000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	47500000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	140400000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	57600000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	158900000	USD
CY2016Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	USD
CY2017Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000000	USD
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P6M
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2017Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	67600000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1100000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-18200000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	7300000	USD
CY2017Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8800000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	900000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11900000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-300000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1100000	USD
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.011
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.005
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.20
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.287
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33400000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	35300000	USD
CY2017Q3	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2016Q4	us-gaap	Goodwill Goodwill	11300000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	12000000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	101100000	USD
	us-gaap	Gross Profit GrossProfit	261700000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	127000000	USD
	us-gaap	Gross Profit GrossProfit	338600000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57900000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2500000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57200000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16400000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18600000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12500000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2200000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8200000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-300000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1400000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2000000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1600000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8900000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2200000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	2200000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	1900000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4100000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3700000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	200000	USD
	us-gaap	Interest Expense InterestExpense	400000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	4500000	USD
	us-gaap	Interest Expense InterestExpense	8100000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	23000000	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15800000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	45400000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	43300000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20100000	USD
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19200000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2300000	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8300000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	300000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1200000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1900000	USD
CY2016Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6600000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8300000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	119000000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	458900000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	402800000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	842900000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	102400000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	118200000	USD
CY2017Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	200000000	USD
CY2017Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2017Q3	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2016Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	399000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38600000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-143300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50800000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-18800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-58200000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-40800000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3300000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6500000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	119600000	USD
	us-gaap	Operating Expenses OperatingExpenses	319500000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	127500000	USD
	us-gaap	Operating Expenses OperatingExpenses	393100000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-18500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-57800000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-54500000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	59500000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	11700000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	11400000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11000000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	10100000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	13100000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	2200000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20000000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	22400000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2100000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1900000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-400000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-600000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1200000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16600000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16700000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	600000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	3200000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1300000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3500000	USD
CY2016Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2600000	USD
CY2017Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	1200000	USD
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	-400000	USD
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	0	USD
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-3600000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	30100000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	141900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38100000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48400000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9200000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13300000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	389000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9900000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	29200000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	47000000	USD
CY2016Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	4800000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	13700000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5000000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	15000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156600000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	188400000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109400000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136100000	USD
CY2017Q3	us-gaap	Recorded Unconditional Purchase Obligation Due Within One Year RecordedUnconditionalPurchaseObligationDueWithinOneYear	78400000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	75000000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	75700000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	207100000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43900000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	112400000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	136700000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-621000000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-662400000	USD
CY2016Q3	us-gaap	Revenues Revenues	148600000	USD
	us-gaap	Revenues Revenues	402100000	USD
CY2017Q3	us-gaap	Revenues Revenues	184600000	USD
	us-gaap	Revenues Revenues	497500000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	256400000	USD
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	29000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	81700000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	25400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	81300000	USD
CY2015Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3300000	USD
CY2016Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7900000	USD
CY2016Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8300000	USD
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	9800000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8300000	USD
CY2017Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8700000	USD
	us-gaap	Stock Issued1 StockIssued1	7200000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	283800000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	384000000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	0	USD
CY2017Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8400000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	84100000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	83300000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	86700000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	86100000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">U.S. GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates include excess or obsolete inventories, valuation of inventory, warranty accruals, convertible debt, employee bonus, clinical trial expenses, allowance for bad debt and refunds and rebates, including pharmacy rebates. </font></div></div>

Files In Submission

Name	View Source	Status
0001093557-17-000221-index-headers.html	Edgar Link	pending
0001093557-17-000221-index.html	Edgar Link	pending
0001093557-17-000221.txt	Edgar Link	pending
0001093557-17-000221-xbrl.zip	Edgar Link	pending
dxcm-20170930.xml	Edgar Link	completed
dxcm-20170930.xsd	Edgar Link	pending
dxcm-20170930_cal.xml	Edgar Link	unprocessable
dxcm-20170930_def.xml	Edgar Link	unprocessable
dxcm-20170930_lab.xml	Edgar Link	unprocessable
dxcm-20170930_pre.xml	Edgar Link	unprocessable
dxcm-93017x10q.htm	Edgar Link	pending
dxcm9302017exhibit3101.htm	Edgar Link	pending
dxcm9302017exhibit3102.htm	Edgar Link	pending
dxcm9302017exhibit3201.htm	Edgar Link	pending
dxcm9302017exhibit3202.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DXCM
DEXCOM INC Stock $dxcm

2017 Q4 Form 10-Q Financial Statement

#000109355717000221 Filed on November 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM DEXCOM INC Stock $dxcm

2017 Q4 Form 10-Q Financial Statement

#000109355717000221 Filed on November 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM
DEXCOM INC Stock $dxcm